X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (12) 12
female (10) 10
aged (9) 9
male (9) 9
middle aged (9) 9
hematology (6) 6
risk (6) 6
adult (5) 5
aged, 80 and over (4) 4
kaplan-meier estimate (4) 4
oncology (4) 4
prognosis (4) 4
analysis (3) 3
cell biology (3) 3
comorbidity (3) 3
hematopoietic-cell transplantation (3) 3
proportional hazards models (3) 3
prospective studies (3) 3
risk factors (3) 3
survival (3) 3
treatment outcome (3) 3
acute myeloid leukemia (2) 2
antifungal agents - therapeutic use (2) 2
apoptosis (2) 2
articles (2) 2
biotechnology & applied microbiology (2) 2
cancer-patients (2) 2
cohort studies (2) 2
death (2) 2
drug therapy (2) 2
genetics (2) 2
geriatric assessment (2) 2
health risk assessment (2) 2
mathematical & computational biology (2) 2
medicine & public health (2) 2
metaanalysis (2) 2
methods (2) 2
models, theoretical (2) 2
molecular biology (2) 2
mortality (2) 2
multiple myeloma - diagnosis (2) 2
multiple myeloma - epidemiology (2) 2
multiple myeloma - mortality (2) 2
multiple-myeloma (2) 2
multivariate analysis (2) 2
mycoses - drug therapy (2) 2
non-hodgkin-lymphoma (2) 2
pharmacology (2) 2
polymorphism, single nucleotide (2) 2
regression-models (2) 2
research article (2) 2
staging system (2) 2
statistics (2) 2
statistics & probability (2) 2
strategy (2) 2
studies (2) 2
survival analysis (2) 2
young adult (2) 2
24-week (1) 1
610 medicine & health (1) 1
abortion (1) 1
abortion, spontaneous - chemically induced (1) 1
abridged index medicus (1) 1
accessibility (1) 1
activation (1) 1
activities of daily living (1) 1
acute myeloid-leukemia (1) 1
add-on (1) 1
advanced basic science (1) 1
adverse events (1) 1
age (1) 1
age-conditional probability of developing cancer (1) 1
aggressive b cell non-hodgkin lymphoma (1) 1
agreements (1) 1
alemtuzumab (1) 1
amphotericin b (1) 1
analysis of variance (1) 1
anesthesiology (1) 1
angina (1) 1
animals (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, murine-derived - administration & dosage (1) 1
antibodies, monoclonal, murine-derived - adverse effects (1) 1
anticoagulants - adverse effects (1) 1
antifungal agents - administration & dosage (1) 1
antifungal agents - adverse effects (1) 1
antigens, cd - immunology (1) 1
antigens, neoplasm - immunology (1) 1
antimycin a (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antiparasitic agents (1) 1
article (1) 1
assaying (1) 1
association (1) 1
bacteremia (1) 1
behavioural change (1) 1
bendamustine hydrochloride (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 04/2015, Volume 21, Issue 7, pp. 1530 - 1536
Conditional survival (CS) is defined as the probability of surviving further t years, given that a patient has already survived s years after the diagnosis of... 
MULTIPLE-MYELOMA | STAGING SYSTEM | ONCOLOGY | Effect Modifier, Epidemiologic | Multiple Myeloma - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Female | Male | Aged
Journal Article
Biometrical Journal, ISSN 0323-3847, 2019
Prognosis is usually expressed in terms of the probability that a patient will or will not have experienced an event of interest t years after diagnosis of a... 
landmark regression models | dynamic prognosis | age-conditional probability of developing cancer | time-dependent bias | conditional survival
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 1/2018, Volume 44, Issue 1, pp. 48 - 60
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2010, Volume 54, Issue 9, pp. 4029 - 4032
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
Hematologic Neoplasms - microbiology | Prospective Studies | Humans | Middle Aged | Mycoses - drug therapy | Adult | Female | Male | Aged | Chromatography, High Pressure Liquid | Antifungal Agents - therapeutic use | Triazoles - therapeutic use | Pharmacology
Journal Article
Cytotherapy, ISSN 1465-3249, 2013, Volume 15, Issue 10, pp. 1237 - 1244
Abstract Background aims The anti-CD52 monoclonal antibody alemtuzumab is employed in allogeneic hematopoietic cell transplantation (alloHCT) for the... 
Advanced Basic Science | Other | Hematopoietic cell transplantation | Reduced intensity conditioning | Alemtuzumab | Natural killer cells | NK cell saving effect | MEDICINE, RESEARCH & EXPERIMENTAL | COMPLEMENT | ACTIVATION | SUBPOPULATIONS | BONE-MARROW | PERIPHERAL-BLOOD | VERSUS-HOST-DISEASE | CELL & TISSUE ENGINEERING | CELL BIOLOGY | natural killer cells | IN-VITRO | alemtuzumab | hematopoietic cell transplantation | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | LYMPHOCYTE ANTIBODY | reduced intensity conditioning | HEMATOLOGY | EXPRESSION | CYTOTOXICITY | Hematologic Neoplasms - therapy | Antigens, CD - immunology | Hematologic Neoplasms - mortality | Humans | Middle Aged | Clinical Protocols | Postoperative Complications - prevention & control | Male | Killer Cells, Natural - pathology | Graft vs Host Disease - immunology | Postoperative Complications - immunology | Transplantation, Homologous | Young Adult | Drug Dosage Calculations | Antibodies, Monoclonal, Humanized - administration & dosage | Adult | Female | Graft vs Host Disease - etiology | Lymphocyte Subsets - pathology | CD52 Antigen | Antibodies, Monoclonal, Humanized - adverse effects | Killer Cells, Natural - transplantation | Antigens, Neoplasm - immunology | Cell Survival | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Glycoproteins - immunology | Survival Analysis | Graft vs Host Disease - prevention & control | Aged | Transplantation Conditioning | Neoplasm Staging | Lymphocyte Subsets - transplantation
Journal Article
Computational Statistics, ISSN 0943-4062, 2/2014, Volume 29, Issue 1, pp. 51 - 63
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2091 - 2091
Abstract Introduction: Disease monitoring based on genetics or other molecular markers obtained by noninvasive or minimally invasive methods will potentially... 
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 4982 - 4982
Abstract Abstract 4982 Introduction: Prior analyses have advocated that mortality from major cancer has declined reflecting continuing progress in cancer... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 4250 - 4250
Abstract Abstract 4250 Introduction: Drug-drug interactions (DDI) may lead to adverse drug events and constitute a risk for patients and a major challenge for... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 1745 - 1745
Abstract Background Prior analyses have advocated that mortality from major cancer has declined reflecting continuing progress in cancer prevention, early... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 733 - 733
Abstract Introduction: In addition to disease-specific and age-related factors, type and severity of comorbidities play a relevant role, influence the... 
Journal Article